| 000 | 01773 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517231839.0 | ||
| 264 | 0 | _c20201123 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1536-3686 | ||
| 024 | 7 |
_a10.1097/MJT.0000000000000823 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoyner, Kayla Rena | |
| 245 | 0 | 0 |
_aMineralocorticoid Receptor Antagonist Utilization in a Nationally Representative Heart Failure With Reduced Ejection Fraction Outpatient Population: A Cross-Sectional Study. _h[electronic resource] |
| 260 |
_bAmerican journal of therapeutics _c |
||
| 300 |
_ae165-e176 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aDrug Prescriptions _xstatistics & numerical data |
| 650 | 0 | 4 | _aEthnicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aOutpatients |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aSoric, Mate Michael | |
| 700 | 1 | _aBoyle, Jaclyn Ann | |
| 700 | 1 | _aMoorman, John Michael | |
| 700 | 1 | _aFredrickson, Mary Elizabeth | |
| 700 | 1 | _aTurosky, Jodie Zlotnik | |
| 700 | 1 | _aKleven, Casondra Lee | |
| 773 | 0 |
_tAmerican journal of therapeutics _gvol. 27 _gno. 2 _gp. e165-e176 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MJT.0000000000000823 _zAvailable from publisher's website |
| 999 |
_c28697428 _d28697428 |
||